Home Companies Oxford Nanopore

Oxford Nanopore

Oxford Nanopore’s London IPO Filing Could Top $5.5 Billion in Value
Companies

Oxford Nanopore’s London IPO Filing Could Top $5.5 Billion in Value

0
The Power of Ultra-Long Reads
Companies

The Power of Ultra-Long Reads

0
In-Surgery Classification of Brain Tumors
Brain Cancer

In-Surgery Classification of Brain Tumors

0
Sequencing and COVID-19 From Genomic Epidemiology to Host Response
Companies

Sequencing and COVID-19 From Genomic Epidemiology to Host Response

0
In-Surgery Classification of Brain Tumors
Brain Cancer

In-Surgery Classification of Brain Tumors

0
Sequencing and COVID-19: From Genomic Epidemiology to Host Response
Companies

Sequencing and COVID-19: From Genomic Epidemiology to Host Response

0
Using Nanopore Sequencing to Study Full-Length Transcripts and Splicing Isoforms
Companies

Using Nanopore Sequencing to Study Full-Length Transcripts and Splicing Isoforms

0
New Tools for Studying Genetic Variation in Cancer
Companies

New Tools for Studying Genetic Variation in Cancer

0
Clinical Research in a Real-Time Sequencing Age
eBooks

Clinical Research in a Real-Time Sequencing Age

0
From Bench to Clinic—The Potential of New Sequencing Tools
Companies

From Bench to Clinic—The Potential of New Sequencing Tools

0
12Page 1 of 2

Trending

X Chromosome-Linked Enzyme May Explain Women’s Higher Alzheimer’s Incidence

X Chromosome-Linked Enzyme May Explain Women’s Higher Alzheimer’s Incidence

Ginkgo Bioworks Acquires Circularis to Strengthen Advanced Therapeutic Capacity

Ginkgo Bioworks Acquires Circularis to Strengthen Advanced Therapeutic Capacity

Amyloid Plaques More Common in White People with Dementia

Amyloid Plaques More Common in White People with Dementia

Alexion, AstraZeneca Rare Disease Acquires LogicBio

Alexion, AstraZeneca Rare Disease Acquires LogicBio

Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.